1. Loeb, J. Comparison of US and European biosimilar regulation and litigation. BioLawGics <
http://www.biolawgics.com/fda-approval/comparison-of-us-and-european-biosimilar-regulation-and-litigation/
> (March 29, 2011)
2. Thomaselli, R. FDA's social media guidelines befuddle big pharma. Ad Age Digital <
http://adage.com/article/digital/fda-s-social-media-guidelines-befuddle-big-pharma/231855/
> (Dec. 30, 2011).
3. Rader, R. FDA biopharmaceutical product approvals and trends: 2011. BIOPHARMA: Biopharmaceutical Products in the US and European Markets. <
http://www.biopharma.com/approvals_2011.html
>
4. DeFrancesco, L. Nat. Biotechnol. 29, 851–852 (2011).
5. Stohl, W. & Hilbeck, D.M. Nat. Biotechnol. 30, 69–77 (2012).